<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.40092.005</object-id><label>Table 1.</label><caption><title>List of participants with ASD or unaffected controls, with the genetic variant(s) involved, and the different iPSC lines derived.</title><p>*The 1 bp deletion in EHMT2 would result in a frameshift 47 codons before the end of the protein and disruption of the stop-codon, potentially leading to the inclusion of a total of 221 incorrect amino acids; more information corresponding to the different genetic variants are presented in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>; MZ, monozygotic; Retro, retrovirus; N/A, not available</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Family ID</th><th valign="top">MSSNG Id</th><th valign="top">Status</th><th valign="top">Primary genetic <break/>variant(s)</th><th valign="top">Sex</th><th valign="top">Age at <break/>reprogramming <break/>(year)</th><th valign="top">Cell of origin</th><th valign="top">Reprogramming <break/>method</th><th valign="top">iPSC ID</th><th valign="top">Reference</th></tr></thead><tbody><tr><td colspan="10" valign="top">ASD Candidate Gene - CNVs</td></tr><tr><td rowspan="2" valign="top">A</td><td valign="top">1-0019-002</td><td valign="top">Unaffected father</td><td valign="top">Family and study control</td><td valign="top">M</td><td valign="top">44</td><td valign="top">Skin</td><td valign="top">Retro</td><td valign="top">19&#8211;2</td><td valign="top"><xref ref-type="bibr" rid="bib12">Deneault et al., 2018</xref></td></tr><tr><td valign="top">1-0019-004</td><td valign="top">ASD-affected</td><td valign="top">16p11.2 deletion/+</td><td valign="top">M</td><td valign="top">15</td><td valign="top">Skin</td><td valign="top">Retro</td><td valign="top">19-4</td><td valign="top"><xref ref-type="bibr" rid="bib39">Marshall et al., 2008</xref></td></tr><tr><td valign="top">B</td><td valign="top">3-0368-000</td><td valign="top">ASD-affected</td><td valign="top"><italic>NRXN1</italic> 430 kb deletion/+</td><td valign="top">M</td><td valign="top">8</td><td valign="top">Skin</td><td valign="top">Retro</td><td valign="top">NR3</td><td valign="top"><xref ref-type="bibr" rid="bib54">Tammimies et al., 2015</xref></td></tr><tr><td rowspan="3" valign="top">C</td><td valign="top">1-0262-002</td><td valign="top">Unaffected father</td><td valign="top">Family control</td><td valign="top">M</td><td valign="top">49</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">16K, 16N</td><td valign="top">---</td></tr><tr><td valign="top">1-0262-003</td><td valign="top">ASD-affected</td><td valign="top"><italic>DLGAP2</italic> 791 kb duplication/+</td><td valign="top">M</td><td valign="top">10</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">15E, 15G</td><td valign="top"><xref ref-type="bibr" rid="bib39">Marshall et al., 2008</xref></td></tr><tr><td valign="top">1-0262-004</td><td valign="top">Affected brother</td><td valign="top">Family control</td><td valign="top">M</td><td valign="top">14</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">17E, 17G</td><td valign="top">---</td></tr><tr><td rowspan="2" valign="top">D</td><td valign="top">1-0582-002</td><td valign="top">Unaffected father</td><td valign="top">Family control</td><td valign="top">M</td><td valign="top">37</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">26E, 26J</td><td valign="top">---</td></tr><tr><td valign="top">1-0582-003</td><td valign="top">ASD-affected</td><td valign="top"><italic>CNTN5</italic> 676 kb deletion</td><td valign="top">M</td><td valign="top">9</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">27H, 27N</td><td valign="top">N/A</td></tr><tr><td valign="top">E</td><td valign="top">7-0058-003</td><td valign="top">ASD-affected</td><td valign="top"><italic>AGBL4</italic> 323 kb deletion/+</td><td valign="top">M</td><td valign="top">4</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">36O, 36P</td><td valign="top">N/A</td></tr><tr><td colspan="10" valign="top">ASD Candidate Gene &#8211; SNVs</td></tr><tr><td rowspan="2" valign="top">F</td><td valign="top">2-1305-005</td><td valign="top">Unaffected brother</td><td valign="top">Family control</td><td valign="top">M</td><td valign="top">7</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">21H, 21P</td><td valign="top">---</td></tr><tr><td valign="top">2-1305-003</td><td valign="top">ASD-affected</td><td valign="top"><italic>CAPRIN1</italic> p.Q399X/+</td><td valign="top">M</td><td valign="top">12</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">20C, 20E, 75G, 75H</td><td valign="top"><xref ref-type="bibr" rid="bib27">Jiang et al., 2013</xref></td></tr><tr><td rowspan="2" valign="top">G</td><td valign="top">2-1186-002</td><td valign="top">Unaffected father</td><td valign="top">Family control</td><td valign="top">M</td><td valign="top">43</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">54E, 54G</td><td valign="top">---</td></tr><tr><td valign="top">2-1186-003</td><td valign="top">ASD-affected</td><td valign="top"><italic>VIP</italic> p.Y73X/+</td><td valign="top">M</td><td valign="top">12</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">53G, 53H</td><td valign="top"><xref ref-type="bibr" rid="bib27">Jiang et al., 2013</xref></td></tr><tr><td rowspan="3" valign="top">H</td><td valign="top">2-1303-004</td><td valign="top">Unaffected brother</td><td valign="top">Family control</td><td valign="top">M</td><td valign="top">13</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">19A</td><td valign="top">---</td></tr><tr><td valign="top">2-1303-003</td><td valign="top">ASD-affected</td><td valign="top"><italic>ANOS1</italic> p.R423X</td><td valign="top">M</td><td valign="top">19</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">18C, 18E</td><td valign="top"><xref ref-type="bibr" rid="bib27">Jiang et al., 2013</xref></td></tr><tr><td valign="top">2-1303-003</td><td valign="top">Corrected ASD-affected</td><td valign="top">CRISPR-corrected <italic>ANOS1</italic> p.X423R</td><td valign="top">M</td><td valign="top">19</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">18CW</td><td valign="top">---</td></tr><tr><td rowspan="2" valign="top">I</td><td valign="top">1-0273-002</td><td valign="top">Unaffected father</td><td valign="top">Family control</td><td valign="top">M</td><td valign="top">45</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">51C, 51E</td><td valign="top">---</td></tr><tr><td valign="top">1-0273-003</td><td valign="top">ASD-affected</td><td valign="top"><italic>THRA</italic> p.R384C/+</td><td valign="top">M</td><td valign="top">14</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">52A, 52C</td><td valign="top"><xref ref-type="bibr" rid="bib64">Yuen et al., 2015</xref></td></tr><tr><td colspan="10" valign="top">Functional ASD Candidate Genes - SNVs</td></tr><tr><td rowspan="3" valign="top">J</td><td valign="top">1-0494-005</td><td valign="top">Unaffected brother</td><td valign="top">Family control</td><td valign="top">M</td><td valign="top">12</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">50A, 50B, 50H</td><td valign="top">---</td></tr><tr><td valign="top">1-0494-003</td><td valign="top">ASD-affected MZ twin</td><td valign="top"><italic>SET</italic> c.112&#160;+&#160;1G&gt;C/+</td><td valign="top">M</td><td valign="top">9</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">48K, 48N</td><td valign="top">N/A</td></tr><tr><td valign="top">1-0494-004</td><td valign="top">ASD-affected MZ twin</td><td valign="top"><italic>SET</italic> c.112&#160;+&#160;1G&gt;C/+</td><td valign="top">M</td><td valign="top">9</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">49H, 49G</td><td valign="top">N/A</td></tr><tr><td rowspan="4" valign="top">K</td><td valign="top">7-0254-001</td><td valign="top">Unaffected mother</td><td valign="top"><italic>GLI3</italic> p.G727R/+</td><td valign="top">F</td><td valign="top">37</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">64N, 64Q</td><td valign="top">---</td></tr><tr><td valign="top">7-0254-002</td><td valign="top">Unaffected father</td><td valign="top"><italic>GLI3</italic> p.G465R/+</td><td valign="top">M</td><td valign="top">41</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">63Q, 63T</td><td valign="top">---</td></tr><tr><td valign="top">7-0254-003</td><td valign="top">ASD-affected</td><td valign="top"><italic>GLI3</italic> p.G727R/+, mat <break/><italic>GLI3</italic> pG465R/+, pat <break/><italic>KIF21A</italic> p.R1156G/+ (mosaic 23%)</td><td valign="top">F</td><td valign="top">7</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">62M, 62X</td><td valign="top">N/A</td></tr><tr><td valign="top">7-0254-004</td><td valign="top">Affected brother</td><td valign="top"><italic>GLI3</italic> p.G727R/+ <break/><italic>GLI3</italic> pG465R/+</td><td valign="top">M</td><td valign="top">9</td><td valign="top">Blood</td><td valign="top">Sendai</td><td valign="top">61I, 61K</td><td valign="top">N/A</td></tr><tr><td rowspan="2" valign="top">L</td><td valign="top">6-0393-001</td><td valign="top">Unaffected mother</td><td valign="top">Family control</td><td valign="top">F</td><td valign="top">54</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">37E</td><td valign="top">---</td></tr><tr><td valign="top">6-0393-003</td><td valign="top">ASD-affected</td><td valign="top">*<italic>EHMT2</italic> p.K1164Nfs/+ <break/><italic>UBE2I</italic> p.E78K/+</td><td valign="top">F</td><td valign="top">18</td><td valign="top">Skin</td><td valign="top">Sendai</td><td valign="top">38B, 38E</td><td valign="top">N/A</td></tr></tbody></table></table-wrap>